Skip to main content

Breadcrumb

  1. Home

Cost, Resource Use, and Efficiency

Valid for Measure Submission

30-Day Risk Standardized All-Cause Emergency Department Visit Following an Inpatient Psychiatric Facility Discharge

The 30-Day Risk Standardized All-Cause Emergency Department Visit Following an Inpatient Psychiatric Facility (IPF) Discharge (IPF ED Visit) measure assesses the proportion of patients ages 18 and older with an emergency department (ED) visit, including observation stays, for any cause, within 30 days of discharge from an IPF, without subsequent admission. The IPF ED Visit measure is an outcome-based measure. 

CBE ID
4190

Cost and Efficiency Advisory Group Meeting

The purpose of this meeting is for Advisory Group members to raise questions and share perspectives verbally regarding the measures under endorsement review for their respective E&M committee. No voting occurs during these virtual meetings.  Rather, Advisory Group members will be asked to review the measures assigned to their respective committee and come to the meeting to ask questions and provide feedback regarding the strengths and limitations of the measures.

Cost and Efficiency Advisory Group Meeting

The purpose of this meeting is for Advisory Group members to raise questions and share perspectives verbally regarding the measures under endorsement review for their respective E&M committee. No voting occurs during these virtual meetings.  Rather, Advisory Group members will be asked to review the measures assigned to their respective committee and come to the meeting to ask questions and provide feedback regarding the strengths and limitations of the measures.

Days at Home for Patients with Complex, Chronic Conditions

This is an ACO-level measure of days at home or in community settings (that is, not in acute care such as inpatient hospital or emergent care settings or post-acute skilled nursing) among adult Medicare Fee-for-Service (FFS) beneficiaries with complex, chronic conditions who are attributed to ACOs participating in the ACO REACH model. The measure includes risk adjustment for differences in patient mix across ACOs, with an additional adjustment based on patients’ risk of death.

CBE ID
4555

E&M Fall 2024 Cost and Efficiency Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

 

E&M Spring 2024 Cost and Efficiency Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.